As a patient at MSK, your child may be able to take part in a clinical trial, also known as a clinical research study. In a clinical trial, doctors evaluate a new therapy or a therapy combination to find out whether it is more effective than current treatments. Nearly every Wilms’ tumor cancer treatment used today exists because of a clinical trial. For every trial, the goal is the same: to provide long-term, disease-free survival.
Our patients have access to many of the latest clinical trials, some of which are available only at MSK. We also participate in many nationwide clinical trials as a founding member of the Children’s Oncology Group, as the coordinating center and co-founder of the Pediatric Oncology Experimental Therapeutics Investigators’ Consortium, and through other trial networks across the United States.
The decision to have your child take part in a clinical trial is entirely up to you and your family. Regardless of whether your child receives standard Wilms’ tumor treatment or therapy through a clinical trial, he or she will benefit from MSK’s ongoing commitment to excellence in patient care.
Learn more about Memorial Sloan Kettering’s current clinical trials for Wilms’ tumor.